GO2 for Lung Cancer Advocates for COVID-19 Vaccine Prioritization
February 17, 2021
Today, GO2 for Lung Cancer joined a broad spectrum of organizations representing laboratory, translational, and clinical researchers; other health care professionals; patients with cancer; and patient advocates in sending a letter to the Biden administration and other public health officials that highlights the importance of prioritizing patients with active cancer and survivors of cancer when administering COVID-19 vaccines.Click here to read the letter.
Lung cancer questions? Contact our free HelpLine at support@go2.org or 1-800-298-2436.